recent trends in radiotherapy for advanced head and neck
play

Recent trends in radiotherapy for advanced head and neck carcinoma - PowerPoint PPT Presentation

Recent trends in radiotherapy for advanced head and neck carcinoma ! Phuc Flix Nguyen-Tn MDCM, FRCP(C) ! Assistant Professor ! Department of Radiation-Oncology ! CHUM Notre-Dame ! Goal of Radiotherapy ! Treat the target volume


  1. Recent trends in radiotherapy for advanced head and neck carcinoma ! Phuc Félix Nguyen-Tân MDCM, FRCP(C) ! Assistant Professor ! Department of Radiation-Oncology ! CHUM Notre-Dame !

  2. Goal of Radiotherapy ! • Treat the target volume while sparing normal tissue !

  3. Intensity-Modulated Radiotherapy (IMRT) ! Radiotherapy delivered with variable beam intensities across the irradiated field !

  4. Conventional Radiotherapy ! Conventional ! Beam Shaper ! Actual Dose Desired Dose Distribution ! Distribution !

  5. Principles of IMRT ! • Each broad radiation beam is divided into a number of smaller beams (beamlets) • Intensities of neighboring beamlets differ • Beams/beamlets enter target from different angles and combine to deliver conformal dose

  6. Intensity Modulated Radiotherapy (IMRT) ! Intensity ! Transmitted ! Modulator ! Beamlets ! Desired Dose Actual Dose Distribution ! Distribution !

  7. Intensity Map ! Port Film ! E.H. !

  8. Patient Immobilization !

  9. 30%, 50%, 75%, 88% ! 30%, 50%, 70%, 85% !

  10. BEV 240 ! BEV 80 ! BEV AP !

  11. Advantages of IMRT ! • High dose volume conforms to the 3-D configuration of the tumor ! • Sparing of nearby normal tissues ! • Option for tumor dose escalation ! • Biologically more effective dose to tumor ! • Improved therapeutic ratio !

  12. 
 Potential Disadvantages ! • Requires greater technical expertise ! • Labor intensive ! • Time consuming ! • Greater target dose inhomogeneity ! • Requires reproducible immobilization ! • More stringent Quality Assurance !

  13. IMRT Methods ! • SMLC : Segmental Multileaf Collimator 
 ! step-and-shoot, stop-and-shoot, ! multisegment ! • DMLC : Dynamic Multileaf Collimator 
 ! sliding window technique ! • IMAT : Intensity-Modulated Arc Therapy ! • Tomotherapy : Sequential (Peacock) 
 ! Helical !

  14. IMRT vs conventional XRT for advanced oropharyngeal carcinoma: The Notre-Dame experience 
 ! (Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):582-9) !

  15. Rational for using IMRT ! • Target delineation improved ! • Dose volume more conformal to the target volume ! • Dose per fraction higher to GTV ! • Treatment time shorter ! • Mean dose higher ! • Better therapeutic ratio !

  16. Objectives ! • Compare acute toxicity and initial response of IMRT vs conventional XRT for patients with advanced carcinoma of the oropharynx treated with concurrent chemotherapy !

  17. Materials ! • 249 patients with oropharyngeal carcinoma ! • 194 men (78%) et 55 women (22%) ! • Median age 57 y.o. (range: 31-79) ! • Stage III (12%) and stage IV (88%) ! • Two groups studied: ! • 100 patients with IMRT ! • 149 patients conventional XRT !

  18. Materials ! • IMRT: ! – 70 Gy in 33 fractions of 2.12 Gy per day ! – Mean dose 73 Gy ! – 6 and a half weeks ! • Conventional XRT ! – 70 Gy in 35 fractions of 2 Gy per day ! – 7 weeks !

  19. Materials ! • Chemotherapy: ! – Carboplatin (70 mg/m2/d x 4 days bolus) ! 5FU ( 600 mg/m2/d continuous infusion) ! !

  20. Results !

  21. IMRT results ! Author ! Site ! No. Patients ! Follow-up Control ! (months) ! Chao ! Oropharynx ! 74 ! 33 ! 87% ! Lee ! Oropharynx ! 41 ! 31 ! 95% ! Eisbruch ! Varied ! 60 ! 32 ! 82% ! De Arruda ! Oropharynx ! 50 ! 18 ! 98% ! Mendenhall ! Base of 22 ! 24 ! 90% ! tongue ! Mendenhall ! Tonsil ! 17 ! 37 ! 100% ! Notre-Dame ! Oropharynx ! 100 ! 35 ! 92% !

  22. Experience with sw-IMRT ! Local F/U control median( Studies Centers N Dose to parotids Xero ≥ Gr2 (%) month) Washington Chao et al 74 33 87 < 26 Gy 30% university De Arruda et 2 Pd <26Gy (26%) 33% MSKCC 50 18 98 al. 1 Pd <26Gy (72%) à 9 months M.D. Anderson Pd Ipsi : <26 Gy Cancer Setton et al. 442 37 95 28% at 3 yr Pd Contro:<22Gy center Pd (lobe sup): mean = Huang et al. USCF 71 33 94 33% at 2 yr 25,5 Gy 1 Pd <26 Gy 2 Pd >20cc <20Gy Clavel et al. CHUM 100 33 95 20% at 2 yr 2 Pd 50% <30Gy

  23. Sw-IMRT vs conventional RT ! Median Doses to parotids Study Centers N F/U LCR (%) Xéro ≥ Gr2 (Gy) (month) PARSPORT Nutting et al., No diff 74% vs 38% (multi- 94 44 Pd Contro: < 24Gy The Lancet (1an) 12 months centrique) oncology 2011 1 Pd <26 Gy 95 82% vs 31% Clavel et al. CHUM 2 Pd >20cc <20Gy 249 42 vs 85 IJROBP 2011 1 year (p=0.042) 2 Pd 50% <30Gy

  24. Conclusion ! • Less grade 3-4 radiodermatitis with IMRT ! • More grade 3-4 mucositis with IMRT ! • Other acute toxicities similar with conventional XRT ! • Better usage of radiobiological principles with IMRT could lead to potential improvement in locoregional control ! • Predict that long term toxicities might decrease, especially xerostomia ! • Potential for better quality of life ! • Effect is difficult to quantify with concurrent chemotherapy !

  25. ¹⁸ F-FDG-PET imaging in radiotherapy tumor volume delineation in treatment of head and neck cancer 
 (Radiother Oncol 2011 Dec;101(3):362-8) 
 !

  26. Objectives/Method ! • Prospective study ! • Evaluate impact of PET/CT to CT alone ! • 29 patients with H&N carcinoma ! • PET-CT done at planification ! • Images reviewed independently ! • Contours done in collaboration with neuroradiologist and nucleist on CT then PET ! – GTV primary et GTV nodes !

  27. Volume of GTVp: CT vs TEP 
 ! • CT • TEP p=0.001

  28. Example of GTV ! • CT • TEP

  29. Volumes of GTVgg: CT vs TEP 
 • CT ! • TEP p=0.08

  30. 
 Negatif adnp on CT and positive on PET 
 ! Ultrasound guided bx: 0/8 were positive !

  31. Metastasis found incidentally !

  32. Conclusions ! • Volume of primary GTV ! – CT > TEP in 80% of cases ! • No difference in volume for adenopathies ! • Treatment altered in 14% of pts ! • Influence on clinical outcome? ! – Potential for decrease toxicities ! – Potential for better locoregional control and survival ! – More studies required !

  33. Is Helical Tomotherapy (HT) superior to sw-IMRT for advanced oropharyngeal carcinoma? 
 The CHUM Notre-Dame experience !

  34. Apparatus and software ! – sw-IMRT: - Eclipse ! ! ! - CORVUS ! ! ! ! – TH: - Helical tomotherapy !

  35. TH vs dose to parotids ! ! Numerous dosimetric studies shown decreased dose to the parotid when comparing sw-IMRT to TH ! ! ! ! ! ! ! ! !

  36. Hypothesis ! • TH compared to sw-IMRT will diminish the dose to the parotids which will translate to similar locoregional control while clinically decrease the incidence of longterm xerostomia !

  37. Objectives "  Compare the dose received to the parotids in patients with advanced oropharyngeal carinoma treated with sw-IMRT vs TH and concomittant chemotherapy !  Compare longterm xerostomia in each group and correlate this with the dose received to the parotids and the XRT technique "

  38. Retrospective study " Eligibility criteria " – Treatments between January 2007 and September 2010 at Notre-Dame Hospital CHUM ! – Locally advanced oropharyngeal ca ! – Curative intent ! – Concomittant chemotherapy with platinum regimen !

  39. Treatment: ! Volumes ! • GTV (Gross tumor volume): primary and adp " " " • CTV1 (clinical tumor volume): ! Tumor + margin + lymphatic drainage ! at high risk ! ! • CTV2: lymphatic drainage at low risk " • PTV1: (Planning target volume): CTV1 + 3-5 mm ! • PTV2: CTV2 + 3-5 mm "

  40. Treatments: ! • Dose " • GTV: 70 Gy in 33 fractions of 2,12 Gy ! • CTV1: 59,4 Gy in 33 fractions of 1,8 Gy " • CTV2: 50,4 Gy in 28 fractions of 1,8 Gy "

  41. Results ! – N = 89 (sw-IMRT = 45 vs TH = 44) ! – Median follow-up 26 months ! !

  42. Locoregional control ! Median F/U 26 months ! !

  43. TH vs mean dose to ipsilateral parotids 
 ! P<0,0001

  44. TH vs dose controlateral parotid 
 ! P<0,0001

  45. Grade of xerostomia: 
 sw- IMRT vs TH ! 100% 90% 80% Grade 3 Grade 2 70% Grade 1 60% Grade 0 50% 40% 30% 20% 10% P < 0,001 0% sw-IMRT 6 mois sw-IMRT 12 mois HT 6 mois HT 12 mois

  46. Discussion ! • Multivariate analysis demonstrated in this series that the XRT technique and the dose to the parotid were the two most predictive factor for the degree of xerostomia ! • IMRT techniques which allow for better sparing of normal tissue such as the parotids leads potentially to a better therapeutic ratio !

  47. Conclusion ! • Recent advances in radiotherapy techniques has translated into better clinical outcome including quality of life issues ! • Evaluation of new technologies is of prime importance to justify not only its clinical relevance but also its costs !

  48. Patients characteristics !

Recommend


More recommend